A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

NCT05920876 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Multiple Myeloma

Interventions

DRUG: QLS32015

Sponsor

Qilu Pharmaceutical Co., Ltd.